Identification of vaccine-derived polioviruses using dual-stage real-time RT-PCR

Journal of Virological Methods

Volumn 197, Issue , 2014, Pages 25-28

  Kilpatrick, David R ^a   Ching, Karen ^a   Iber, Jane ^a   Chen, Qi ^a   Yang, Su Ju ^a   De, Lina ^a   Williams, A J ^a   Mandelbaum, Mark ^a   Sun, Hong ^a   Oberste, M Steven ^a   Kew, Olen M ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Poliovirus; Real time RT PCR; Vaccine derived poliovirus; VDPV

Indexed keywords

POLIOMYELITIS VACCINE;

ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENOME ANALYSIS; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SEROTYPE; VACCINE DERIVED POLIOVIRUS; VIRUS CAPSID; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS STRAIN;

POLIOVIRUS; REAL-TIME RT-PCR; VACCINE-DERIVED POLIOVIRUS; VDPV;

HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINES; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TIME FACTORS; VIROLOGY;

EID: 84891132800     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2013.11.017     Document Type: Article

References (34)

1. Alexander J.P., Gary H.E., Pallansch M.A. Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J. Infect. Dis. 1997, 175:S176-S182.
2. Balanant J., Guillot S., Candréa A., Delpeyroux F., Crainic R. The natural genomic variability of poliovirus analyzed by a restriction fragment polymorphism assay. Virology 1991, 184:645-654.
3. Burns C., Shaw J., Jorba J., Bukbuk D., Adu F., Gumede N., Iber J., Chen Q., Vincent A., Chenoweth P., Henderson E., Wannemeuhler K., Campagnoli R., Pate M.A., Abanida E., Gasasira A., Shimizu H., Williams A.J., Kilpatrick D., Wassilak S., Tomori O., Pallansch M., Kew O. Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J. Virol. 2013, 87:4907-4922.
4. Centers for Disease Control and Prevention Laboratory surveillance for wild and vaccine-derived polioviruses-worldwide, January 2008-June 2009. Morbid. Mortal. Wkly. Rep. 2009, 58:950-954.
5. Centers for Disease Control and Prevention Update on vaccine-derived polioviruses-worldwide, April 2011-June 2012. Morbid. Mortal. Wkly. Rep. 2012, 61:741-746.
6. Centers for Disease Control and Prevention Evaluating surveillance indicators supporting the Global Polio Eradication Initiative, 2011-2012. Morbid. Mortal. Wkly. Rep. 2013, 62:270-274.
7. De L., Nottay B.K., Yang C.-F., Holloway B.P., Pallansch M.A., Kew O. Identification of vaccine-related polioviruses by hybridization with specific RNA probes. J. Clin. Microbiol. 1995, 33:562-571.
8. DeVries A.S., Harper J., Murray A., Lexau C., Bahta L., Christensen J., Cebelinski E., Fuller S., Kline S., Wallace G.S., Shaw J.H., Burns C.C., Lynfield R. Vaccine-derived poliomyelitis 12 years after infection in Minnesota. N. Engl. J. Med. 2011, 364:2316-2323.
9. Jegouic S., Joffret M.-L., Blanchard C., Riquet F.B., Perret C., Pelletier I., Colbere-Garapin F., Rakoto-Andrianarivelo M., Delpeyroux F. Recombination between polioviruses and co-circulating Coxsackie A viruses: role in the emergence of pathogenic vaccine-derived polioviruses. PLoS Pathog. 2009, 5:e1000412.
10. Jorba J., Campagnoli R., De L., Kew O. Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J. Virol. 2008, 82:4429-4440.
11. Kew O.M., Morris-Glasgow V., Landaverde M., Burns C., Shaw J., Garib Z., André J., Blackman E., Freeman C.J., Jorba J., Sutter R., Tambini G., Venczel L., Pedreira C., Laender F., Shimizu H., Yoneyama T., Miyamura T., van der Avoort H., Oberste M.S., Kilpatrick D., Cochi S., Pallansch M., de Quadros C. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 2002, 296:356-359.
12. Kew O.M., Sutter R.W., de Gourville E.M., Dowdle W.R., Pallansch M.A. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu. Rev. Microbiol. 2005, 59:587-635.
13. Kilpatrick D.R., Nottay B., Yang C.-F., Yang S.-J., Mulders M.N., Holloway B.P., Pallansch M.A., Kew O.M. Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy. J. Clin. Microbiol. 1996, 34:2990-2996.
14. Kilpatrick D.R., Nottay B., Yang C.-F., Yang S.-J., da Silva E., Peñaranda S., Pallansch M., Kew O. Serotype-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy. J. Clin. Microbiol. 1998, 36:352-357.
15. Kilpatrick D.R., Ching K., Iber J., Campagnoli R., Freeman C.J., Mishrik N., Pallansch M.A., Kew O.M. Multiplex PCR method for identifying recombinant vaccine-related polioviruses. J. Clin. Microbiol. 2004, 42:4313-4315.
16. Kilpatrick D.R., Yang C.-F., Ching K., Vincent A., Iber J., Campagnoli R., Mandelbaum M., De L., Yang S.-J., Nix A., Kew O.M. Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues. J. Clin. Microbiol. 2009, 47:1939-1941.
17. Liang X., Zhang Y., Xu W., Wen N., Zou S., Lee L.A., Yu J. An outbreak of poliomyelitis caused by type 1 vaccine-derived poliovirus in China. J. Infect. Dis. 2006, 194:545-551.
18. MacLennan C., Dunn G., Huissoon A.P., Kumararatne D.S., Martín J., O'Leary P., Thompson R.A., Osman H., Wood P., Minor P., Wood D.J., Pillay D. Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. Lancet 2004, 363:1509-1513.
19. Martín J., Dunn G., Hull R., Patel V., Minor P.D. Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J. Virol. 2000, 74:3001-3010.
20. Minor P.D. Antigenic structure of picornaviruses. Curr. Top. Microbiol. Immunol. 1990, 161:121-154.
21. Rousset D., Rakoto-Andrianarivelo M., Razafindratsimandresy R., Randriamanalina B., Guillot S., Balanant J., Mauclère P., Delpeyroux F. Recombinant vaccine-derived poliovirus in Madagascar. Emerg. Infect. Dis. 2003, 9:885-887.
22. Shimizu H., Thorley B., Paladin F.J., Brussen K.A., Stambos V., Yuen L., Utama A., Tano Y., Arita M., Yoshida H., Yoneyama T., Benegas A., Roesel S., Pallansch M., Kew O., Miyamura T. Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J. Virol. 2004, 78:13512-13521.
23. Sutter R.W., Kew O.M., Cochi S.L., Aylward R.B. Poliovirus vaccine-live. Vaccines 2013, 598-645. W.B. Saunders, London. S.A. Plotkin, W.A. Orenstein, P.A. Offit (Eds.).
24. Toyoda H.M., Kohara M., Kataoka Y., Suganuma T., Omata T., Imura N., Nomoto A. Complete nucleotide sequences of all three poliovirus serotype genomes: implication for genetic relationship, gene function and antigenic determinants. J. Mol. Biol. 1984, 174:561-585.
25. van der Avoort H.G.A.M., Hull B.P., Hovi T., Pallansch M.A., Kew O.M., Crainic R., Wood D.J., Mulders M.N., van Loon A.M. A comparative study of five methods of intratypic differentiation of polioviruses. J. Clin. Microbiol. 1995, 33:2562-2566.
26. Vidor E., Plotkin S.A. Poliovirus vaccine-inactivated. Vaccines 2013, 573-597. W.B. Saunders, London. S.A. Plotkin, W.A. Orenstein, P.A. Offit (Eds.).
27. Wassilak S., Pate M.A., Wannemuehler K., Jenks J., Burns C., Chenoweth P., Abanida E.A., Adu F., Baba M., Gasasira A., Iber J., Mkanda P., Williams A.J., Shaw J., Pallansch M., Kew O. Outbreak of type 2 vaccine-derived poliovirus in Nigeria, 2005-2009: emergence and widespread circulation in an underimmunized population. J. Infect. Dis. 2011, 203:898-909.
28. World Health Organization Polio Laboratory Manual 2004, World Health Organization, Geneva. 4th ed.
29. World Health Organization Polio vaccines and polio immunization in the pre-eradication era. WHO position paper. Wkly. Epidemiol. Rec. 2010, 85:213-228.
30. World Health Organization Progress towards global interruption of wild poliovirus transmission. January 2012-March 2013. Wkly. Epidemiol. Rec. 2013, 88:181-187.
31. Yakovenko M.L., Cherkasova E.A., Rezapkin G.V., Ivanova O.E., Ivanov A.P., Eremeeva T.P., Baykova O.Y., Chumakov K.M., Agol V.I. Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties. J. Virol. 2006, 80:2641-2653.
32. Yan D., Li L., Zhu S., Zhang Y., An J., Wang D., Wen N., Jorba J., Liu W., Zhong G., Huang L., Kew O., Liang X., Xu W. Emergence and localized circulation of a vaccine-derived poliovirus in an isolated mountain community in Guangxi, China. J. Clin. Microbiol. 2010, 48:3274-3280.
33. Yang C.-F., De L., Holloway B.P., Pallansch M.A., Kew O.M. Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res. 1991, 20:159-179.
34. Yang C.-F., Chen H.-Y., Jorba J., Sun H.-C., Yang S.-J., Lee H.-C., Huang Y.-C., Lin T.-Y., Chen P.-J., Shimizu H., Nishimura Y., Utama A., Pallansch M., Miyamura T., Kew O., Yang J.-Y. Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient. J. Virol. 2005, 79:12623-12634.